-
Leinster survive Toulon scare to reach Champions Cup final
-
Villarreal secure Champions League spot, rotated Atletico win
-
'Relieved' Inoue outlasts Nakatani in Tokyo Dome superfight
-
Israel quizzes two Gaza flotilla activists, angering Spain
-
West Ham defeat gives Spurs hope, Arsenal face Fulham test
-
Second-string Bayern held by Heidenheim before PSG clash
-
Lyon edge Arsenal to reach women's Champions League final
-
Struggling Nantes deepen Marseille's woes in Ligue 1
-
Harmanpreet Kaur to lead India in women's T20 World Cup
-
Pogacar wins again to pull clear in Tour of Romandie
-
New Zealand win rain-hit T20 to end Bangladesh series 1-1
-
Inoue outlasts Nakatani in Tokyo Dome superfight
-
Taiwan leader makes delayed visit to Eswatini after China objections
-
Iran military official says renewed war with US 'likely'
-
Coe will be 'tough' on athletes seeking nationality switch
-
Illegal rave draws 20,000 to 'dangerous' military site in France
-
US rapper Kanye West to perform in Albania in July
-
Ex-F1 driver turned Paralympic champion Zanardi dies
-
In Vietnam, Japan PM vows more effort to keep Asia 'free and open'
-
Humpback whale stranded in Germany released into North Sea: media
-
Japan PM meets top Vietnam leaders in Hanoi
-
Spirit Airlines begins 'wind-down', cancels all flights
-
Japan PM to meet top Vietnam leaders in Hanoi
-
Raisin moonshine banned in Iran enjoys resurgence in New York
-
Lebanon says 13 killed in Israeli strikes in south
-
Judge Hears Landmark Hemp-Marijuana Challenge to Medicare Medicaid Reimbursing Payment Program
-
Prometheus Laboratories Showcases Drug Clearance as a Foundation for Precision Guided Biologic Dosing in IBD at DDW 2026
-
Next-Generation Sound Arrives: Kiwi Ears Launches Halcyon Tribrid IEM on Kickstarter
-
No.1 Korda charges into share of LPGA Mexico lead
-
Young fires 67 to seize commanding PGA lead at Doral
-
US appeals court temporarily halts mail delivery of abortion pill
-
Joy for Norris in Miami as McLaren end Mercedes run
-
Leclerc offers hope to Ferrari fans in Miami
-
US to withdraw about 5,000 troops from Germany
-
'No going back' for Colombia's workers as the right eyes return
-
Norris on sprint pole as McLaren shine again
-
Venezuelan protesters call government wage hike a joke
-
Leeds beat Burnley to virtually secure Premier League survival
-
Gridlock as pandemic treaty talks fail to finish
-
S&P 500, Nasdaq end at fresh records on tech earnings strength
-
Immersive art: museum-goers in bikinis dive into Cezanne
-
Gaza activists disperse after flotilla halted by Israel off Crete
-
US sanctions are 'collective punishment,' says Cuba during May 1 marches
-
Top seeds Sinner, Zverev reach Madrid Open final
-
Pope names former undocumented migrant as US bishop of West Virginia
-
Delhi end slump with team-record chase against Rajasthan
-
Trump says will raise US tariffs on EU cars to 25%
-
AI actors and writers not eligible for Oscars: Academy
-
Rebels take key military base in Mali's north
-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq considers the matter closed.
About Modular Medical
Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
[email protected]
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
B.Finley--AMWN